Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

2024 SABCS Annual Meeting Insights Hub
J

SABCS 2024 Insights: BWEL Trial - Impact of Weight Loss Intervention on Metabolic and Inflammatory Biomarkers in Obese Women With BC

By 2024 SABCS Annual Meeting Insights Hub FEATURING Jennifer Ligibel
By 2024 SABCS Annual Meeting Insights Hub FEATURING Jennifer Ligibel
42 views
February 7, 2025
Comments 0
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

14:18
Incyte

Early Intervention in Chronic GVHD: Evaluating Efficacy and Safety O…

Feat. H. Ali
Breast
15:34

SABCS 2024 Insights: BWEL Trial - Impact of Weight Loss Intervention…

2024 SABCS Annual Meeting Insights Hub

J. Ligibel

42 views
08:33

Management of HER2+ mBC: Treatment Decisions After T-DXd Progression

Dana-Farber Cancer Institute

G. Nader-Marta

110 views
12:22

SABCS 2024 Summary: Next-Generation SERDs and Their Clinical Applica…

2024 SABCS Annual Meeting Insights Hub

R. Jeselsohn

177 views
14:52

SABCS 2024 Summary: Evolution of SERDs - Limitations of Fulvestrant …

2024 SABCS Annual Meeting Insights Hub

R. Jeselsohn

55 views
07:58

SABCS 2024 Insights: Tumor-Infiltrating Lymphocytes and Response to …

2024 SABCS Annual Meeting Insights Hub

M. Tesch

82 views
01:56

SABCS 2024 Insights: Valemetostat + T-DXd in Previously Treated, Unr…

2024 SABCS Annual Meeting Insights Hub

S. Tolaney

11 views
02:18

SABCS 2024 Insights: EmpowHER 303 - Zanidatamab vs. Trastuzumab + Ch…

2024 SABCS Annual Meeting Insights Hub

S. Tolaney

27 views
02:25

ESMO 2024 Insights: Quantitative High Sensitivity HER2 Testing With …

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

374 views
02:49

ESMO 2024 Insights: Real-World Characteristics of NATALEE and monarc…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

252 views
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

1.7K views
12:14

ASCO® 2024 Breast Cancer Highlights: Top 5 Abstracts - DESTINY-Breas…

2024 ASCO® Annual Meeting Insights Hub

P. Tarantino

2.5K views
08:07

ASCO® 2024 Insights: "SACI-IO HR+ Trial - Sacituzumab Govitecan +/- …

2024 ASCO® Annual Meeting Insights Hub

A. Garrido-Castro

285 views
06:10

ESMO Breast 2024 Summary: "Is There a Role for Combining ADCs With t…

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney

859 views
08:18

ESMO Breast 2024 Insights: "Is There a Role for Combining PARP Inhib…

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney

337 views
05:35

ESMO Breast 2024 Insights: "IMpassion132 Trial - Is There a Role for…

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney

531 views
21:20

Older Adults With Breast Cancer: Research Updates

Dana-Farber Cancer Institute

R. Freedman

273 views
14:16

Year in Review: Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

2.4K views
22:34

What's New in Breast Cancer?

Dana-Farber Cancer Institute

S. Tolaney

1.6K views
17:35

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HER2CLIMB-0…

Insights from 2023 SABCS

P. Tarantino

1.1K views
17:20

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNOTE-75…

Insights from 2023 ESMO Annual Meeting

P. Tarantino

2.1K views
12:50

Expert Perspectives in the Management of TNBC

Oncology Data Advisor

S. Tolaney

756 views
09:32

ASCO® 2023 Insights: "TROPiCS-02 Phase 3 Study Final OS Analysis - S…

Insights from 2023 ASCO® Annual Meeting

S. Tolaney

712 views
04:28

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant Sacit…

Insights from 2023 ASCO® Annual Meeting

S. Tolaney

2.3K views
12:48

ASCO® 2023 Insights: "Association of Tumor-Infiltrating Lymphocytes …

Insights from 2023 ASCO® Annual Meeting

M. Tesch

124 views
11:01

Updates on the Personalized Management of HER2+ eBC for 2023

Dana-Farber Cancer Institute

A. Waks

94 views
14:11

ESMO Breast Cancer 2023 Highlights: Key Studies Including IMPassion0…

ESMO Breast Cancer 2023 Congress Coverage

P. Tarantino

775 views
31:07

Supporting Older Adult Cancer Survivors With a Focus on Breast Cancer

Dana-Farber Cancer Institute

R. Freedman

84 views
39:42

Probing Genome Maintenance Mechanism Through the Lens of BRCA1/2 Syn…

Dana-Farber Cancer Institute

D. Durocher

77 views
33:37

PARPi in Ovarian Cancer: Maximizing Risk/Benefit Ratio

Dana-Farber Cancer Institute

E. Swisher

203 views
33:35

Advances in the Systemic Treatment of BRCA1/2 and PALB2-Associated B…

Dana-Farber Cancer Institute

F. Lynce

102 views
38:50

New Vulnerabilities in BRCAm Cancers

Dana-Farber Cancer Institute

R. Greenberg

48 views
29:11

Redefining BRCAness and Chemotherapy Response

Dana-Farber Cancer Institute

S. Cantor

20 views
36:28

Complexities of Utilizing Immunotherapy in BRCA-Associated Cancers

Dana-Farber Cancer Institute

J. Guerriero

128 views
34:05

Dana-Farber Cancer Institute 2022 SABCS Updates on mBC

Dana-Farber Cancer Institute

H. Burstein

195 views
13:32

Impact of DESTINY-Breast04 Data in HER2-Low Breast Cancer: How to Im…

Dana-Farber Cancer Institute

P. Tarantino

969 views
06:04

Updated Exploratory Analysis of the HER2CLIMB Trial for HER2+ mBC Wi…

Dana-Farber Cancer Institute

N. Lin

389 views
06:53

SABCS 2022 Primary Results From the POSITIVE Trial: Interruption of …

ecancer

A. Partridge

596 views
05:45

SABCS 2022 Adjuvant Paclitaxel & Trastuzumab for Node- HER2+ BC: Fin…

SABCS 2022 Conference Coverage

S. Tolaney

1.9K views
02:31

SABCS 2022 Phase 3 TROPiCS-02 Study: Exposure-Adjusted Incidence Rat…

SABCS 2022 Conference Coverage

S. Tolaney

78 views
16:49

SABCS 2022 Inflammatory Breast Cancer: A Perfect Storm

SABCS 2022 Conference Coverage

F. Lynce

317 views
14:58

SABCS 2022 Poster Reviews of Special Populations: Male Breast Cancer

SABCS 2022 Conference Coverage

J. Pablo Leone

249 views
14:31

An Overview of Male Breast Cancer

Dana-Farber Cancer Institute

J. Pablo Leone

79 views
07:56

Aiming at a Tailored Cure for ERBB2+ Metastatic Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

170 views
04:19

ESMO 2021 Update on T-DXd +/- Pertuzumab vs. THP in 1L HER2+ MBC: DE…

Dana-Farber Cancer Institute

S. Tolaney

334 views
11:30

Optimizing Treatment of MBC: Predictive / Prognostic Biomarkers, Ove…

i3 Health

S. Tolaney, I. Bleiweiss, M. Ross

30 views
07:55

2021 ASCO Updates From eMonarcHER on HR+, HER2+, N+, High-Risk eBC: …

Dana-Farber Cancer Institute

S. Tolaney

380 views
09:08

Results from monarcHER Trial on CDK4/6 Inhibitors + ET: Can Abemacic…

Dana-Farber Cancer Institute

S. Tolaney

554 views
25:16

Endocrine Therapy in Advanced HR+/HER2- Beyond 2020: Addition of CDK…

Dana-Farber Cancer Institute

E. Mayer

1.5K views
07:38

2019 APHINITY Trial Update: Fewer Deaths Seen in Addition of Pertuzu…

Dana-Farber Cancer Institute

S. Tolaney

1.4K views
07:23

Study of Ribociclib and PDR001 in HR+ Metastatic Breast Cancer

Dana-Farber Cancer Institute

S. Tolaney

1.8K views
07:40

Study of Carboplatin plus Nivolumab in Metastatic Triple-Negative Br…

Dana-Farber Cancer Institute

S. Tolaney

5.5K views
07:43

Study of Abemaciclib for Patients with RB-Positive, Triple Negative …

Dana-Farber Cancer Institute

S. Goel

925 views